Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Drug Testing and Analysis|June 24, 2026
Exploring the Potential of Population-Optimized Red Blood Cell Antigens and Platelet HLA Typing for Homologous Blood Transfusion Detection in Japanese AthletesAtsushi Momobayashi, Masato OkanoDrug Testing and Analysis|May 10, 2024
Individual identification method using samples associated with doping tests: A comparison of mitochondrial and nuclear genetic dataKentaro Akiyama, Atsushi Momobayashi, Masato OkanoAnalytical and Bioanalytical Chemistry|June 16, 2025
Direct detection of CRISPR-Cas9 ribonucleoprotein gene doping using RNA immunoprecipitation and quantitative PCRKentaro Akiyama, Atsushi Momobayashi, Masato OkanoEuropean Journal of Endocrinology|May 31, 2007
Changes in expression of T-helper (Th) 1- and Th2-associated chemokine receptors on peripheral blood lymphocytes and plasma concentrations of their ligands, interferon-inducible protein-10 and thymus and activation-regulated chemokine, after antithyroid drug administration in hyperthyroid patients with Graves' diseaseYoshihisa Inukai, Atsushi Momobayashi, Naoto Sugawara, et al.Translational Research : the Journal of Laboratory and Clinical Medicine|August 20, 2014
Bezafibrate, a peroxisome proliferator-activated receptor α agonist, decreases circulating CD14(+)CD16(+) monocytes in patients with type 2 diabetesTomoko Terasawa, Yoshimasa Aso, Kyoko Omori, et al.Diabetes Research and Clinical Practice|October 29, 2015
Sitagliptin, a DPP-4 inhibitor, alters the subsets of circulating CD4+ T cells in patients with type 2 diabetesYoshimasa Aso, Maiko Fukushima, Masaaki Sagara, et al.Endocrine Journal|May 24, 2006
Profound reduction in T-helper (Th) 1 lymphocytes in peripheral blood from patients with concurrent type 1 diabetes and Graves' diseaseYoshimasa Aso, Hiromi Matsuura, Atsushi Momobayashi, et al.Diabetes Research and Clinical Practice|October 5, 2010
Relation between serum high molecular weight adiponectin and serum ferritin or prohepcidin in patients with type 2 diabetesYoshimasa Aso, Kohzo Takebayashi, Sadao Wakabayashi, et al.Drug Testing and Analysis|October 8, 2022
Doping control analyses during the Tokyo 2020 Olympic and Paralympic GamesMasato Okano, Ayako Ikekita, Mitsuhiko Sato, et al.Pageof 1